GSK
GSK appoint HSBC director Iain Mackay as new CFO
August 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Iain Mckay, cfo, hsbc
British pharma giant GlaxoSmithKline have appointed HSBC Group Finance Director, Iain Mackay, as its new Chief Financial Officer. The move …
Top Ten most popular articles on Pharmafile.com this week
August 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, GSK, Sanofi, brexit, pharmafile, top 10
While average temperatures dropped to a comfortable 22 degrees, the past week has put the EMA in a sticky position …
GSK announces closure of Bangladesh facilities
July 30, 2018Manufacturing and Production Bangladesh, Chittagong, GSK, closure, manufacturing
The British multinational GlaxoSmithKline has announced the closure of its facilities in Bangladesh after more than six decades of operation …
Top Ten most popular articles on Pharmafile.com this week
July 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, China, GSK, Gilead, J&J, JJ, Pfizer, Remicade, Roche, antimicrobial resistance, biosimilar, pharma, pricing, viagra
With the UK in the grip of a record-breaking heatwave, it’s hard to focus on much else over here, but …
GSK forges $300m partnership with 23andMe to boost preclinical R&D
July 26, 2018Research and Development 23andME, GSK, GlaxoSmithKline, collaboration, genetics, pharma
In a bid to supercharge its drug discovery efforts, GlaxoSmithKline has sealed a $300 million deal with personal genomics and …
Employees protest against shutting down of GSK facility in Bangladesh
July 24, 2018Manufacturing and Production Bangladesh, GSK, manufacturing, protest, union
Employees of the British multinational GlaxoSmithKline (GSK) have led a protest against the shutting down of manufacturing facilities in Bangladesh. …
First new treatment for reccurent malaria approved in over 60 years
July 23, 2018Manufacturing and Production FDA, GSK, approval, malaria, p.vivax
The FDA has approved GSK’s Krintafel for the treatment of a recurring form of malaria in patients aged 16 and …
Top Ten most popular articles on Pharmafile.com this week
July 20, 2018Medical Communications GSK, ICR, J&J, JJ, Novartis, Trump, brexit, top 10
As Brexit negotions have hit a stalemate this week, the United Kingdom’s exit from the European Union has hit the …
GSK confirms £250m deal to sell experimental drug to Dermavent Sciences
July 13, 2018Medical Communications Dermavent, GSK, Roivant, tapinarof
British company GlaxoSmithKline has announced that it will sell the rights to its experimental dermatology drug, tapinarof, to Roivant Sciences’ …
FDA knocks back Mylan’s Advair generic for second time
June 14, 2018Sales and Marketing Advair, FDA, GSK, Mylan, pharma
The FDA has rejected Mylan’s generic version of GlaxoSmithKline’s Advair for the second time following its knockback last year, citing …
AZ’s hopes for Fasenra in COPD suffer terminal blow
May 30, 2018Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical
It looked unlikely that Fasenra would achieve success in the chronic obstructive pulmonary disease (COPD) area, after it suffered in …
Top Ten most popular articles on Pharmafile.com this week
May 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical
It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …
AZ’s Fasenra stumbles in P3 for COPD
May 11, 2018Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical
AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …
GSK’s CFO chooses to exit company
May 9, 2018Medical Communications GSK, biotech, drugs, pharma, pharmaceutical
Simon Dingemans has been Chief Financial Officer at GSK since 2011 but has now chosen to retire from the position …
Top Ten most popular articles on Pharmafile.com this week
March 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten
As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
